Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01299363 · ClinicalTrials.gov registry record · Phase 4
Dilators for Dyspareunia Prevention
A Phase 4 study, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT01299363 is a Phase 4 study that has completed, run by Medstar Health Research Institute. The registered enrollment target is 60 participants.
The verdict
NCT01299363, a Phase 4 study, has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
This is a randomized clinical trial comparing rates of de novo dyspareunia in women with and without vaginal dilator use following surgery for pelvic organ prolapse with traditional posterior repair. Our hypothesis is daily use of vaginal dilators from post-op week 4 through week 8 after posterior repair will reduce the rate of de novo dyspareunia.
Interventions
- BEHAVIORAL Dilator use
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2010-09 |
| Est. Completion | 2013-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01299363
The ClinicalTrials.gov registry entry for NCT01299363 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dilator use is the first listed.
NCT01299363 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01299363 about?
NCT01299363 is a clinical study titled "Dilators for Dyspareunia Prevention". This is a randomized clinical trial comparing rates of de novo dyspareunia in women with and without vaginal dilator use following surgery for pelvic organ prolapse with traditional posterior repair. Our hypothesis is daily use of vaginal dilators from post-op week 4 through week 8 after posterior r...
What is the current status of trial NCT01299363?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2010-09. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01299363?
The interventions under investigation include: Dilator use (BEHAVIORAL).
Who is sponsoring clinical trial NCT01299363?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.